Trials / Completed
CompletedNCT06775834
Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function
Safety and Pharmacokinetic Study of HRS-1893 Tablets in Subjects With Mild and Moderate Renal Insufficiency and Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Shandong Suncadia Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The primary objective is to evaluate pharmacokinetics of HRS-1893 tablets in subjects with impaired kidney function in comparison with healthy subjects, to develop dose recommendations for patients with renal impairment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-1893 | HRS-1893 tablets. |
Timeline
- Start date
- 2025-02-11
- Primary completion
- 2025-07-23
- Completion
- 2025-07-23
- First posted
- 2025-01-15
- Last updated
- 2025-09-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06775834. Inclusion in this directory is not an endorsement.